Market Size in 2020 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 4.5 Billion | USD 10.1 Billion | 5.3% | 2020 |
The global Lab Automation market accrued earnings worth approximately 4.5 (USD Billion) in 2020 and is predicted to gain revenue of about 10.1(USD Billion) by 2028, is set to record a CAGR of nearly 5.3% over the period from 2021 to 2028.
The report offers assessment and analysis of the Lab Automation market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2020 along with a forecast from 2021 to 2028 based on revenue (USD Billion).
Lab automation is a multi-disciplinary approach towards optimization of use of lab technologies for bringing enhancement in clinical processes. Lab automation experts comprise of academics, researchers, engineers, and scientists who carry out research along with developing novel techniques for enhancing efficiency and improving quality of clinical data. Apart from this, lab automation assists in reducing lab process cycle period and facilitates research activities. Reportedly, extensive use of lab automation technique is lab robots. Moreover, lab automation includes automated lab devices such as auto-samplers and lab automated systems are embedded with software programs & methods facilitating efficacy of scientific research processes in labs.
Growth of lab automation industry over forecast timeframe can be credited to massive requirement for improving efficacy of drug discovery process as well as clinical diagnostics procedures. Moreover, lab automation provides high output and reduced regent costs. In addition to this, enhanced healthcare infrastructure witnessed across developing economies and thriving biotech & pharma sectors will boost market size in years ahead. Large-scale utilization of automated equipment in academic & research institutes will help latter to focus on high priority tasks and this will culminate into huge penetration of lab automation products across research & development activities across globe, thereby driving industry space.
Apparently, use of automated devices by drug discovery units of pharma firms will further scale up growth of lab automation industry. Moreover, lab automation will offer lucrative benefits to clinical labs and make its operations more proficient, reliable, and secured. This, in turn, will enlarge scope of lab automation market over years ahead.
Report Attributes | Report Details |
---|---|
Report Name | Lab Automation Market Research Report |
Market Size in 2020 | USD 4.5 Billion |
Market Forecast in 2028 | USD 10.1 Billion |
Growth Rate | CAGR of 5.3% |
Number of Pages | 210 |
Key Companies Covered | Qiagen N.V., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, Bio Tek Instruments, Inc., F. Hoffmann-La Roche, Hamilton Company, Aurora Biomed Inc., BMG LABTECH GMBH, Siemens Healthineers, Hudson Robotics, Eppendorf AG, Tecan Group Ltd., and PerkinElmer Inc. |
Segments Covered | By Product, By End-User, By Application and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2020 |
Historical Year | 2016 to 2020 |
Forecast Year | 2020 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Key players impacting growth of lab automation industry and profiled in report include Qiagen N.V., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, Bio Tek Instruments, Inc., F. Hoffmann-La Roche, Hamilton Company, Aurora Biomed Inc., BMG LABTECH GMBH, Siemens Healthineers, Hudson Robotics, Eppendorf AG, Tecan Group Ltd., and PerkinElmer Inc.
North America To Dominate Global Regional Market Landscape By 2028
Rapid expansion of lab automation market in North America over assessment period is subject to humungous presence of giant pharma firms in countries such as the U.S. In addition to this, huge government funding made in drug discovery & genomics research projects will promulgate expansion of lab automation industry over forecast timeline during assessment timespan.
Strong presence of established healthcare infrastructure facility and favorable compensation policies will steer growth of lab automation business in North America over upcoming years.
The global Lab Automation market profiles key players such as:
By Product
By End-User
By Application
By Region
FrequentlyAsked Questions
Growth of lab automation industry over forecast timeframe can be credited to massive requirement for improving efficacy of drug discovery process as well as clinical diagnostics procedures. Moreover, lab automation provides high output and reduced regent costs. In addition to this, enhanced healthcare infrastructure witnessed across developing economies and thriving biotech & pharma sectors will boost market size in years ahead. Large-scale utilization of automated equipment in academic & research institutes will help latter to focus on high priority tasks and this will culminate into huge penetration of lab automation products across research & development activities across globe, thereby driving industry space. Apparently, use of automated devices by drug discovery units of pharma firms will further scale up growth of lab automation industry. Moreover, lab automation will offer lucrative benefits to clinical labs and make its operations more proficient, reliable, and secured. This, in turn, will enlarge scope of lab automation market over years ahead.
According to Zion market research report, the global Lab Automation market accrued earnings worth approximately 4.5 (USD Billion) in 2020 and is predicted to gain revenue of about 10.1(USD Billion) by 2028, is set to record a CAGR of nearly 5.3% over the period from 2021 to 2028.
North America will contribute lucratively towards the global market value over the estimated timeline. The regional market surge is subject to humungous presence of giant pharma firms in countries such as the U.S. In addition to this, huge government funding made in drug discovery & genomics research projects will promulgate expansion of lab automation industry over forecast timeline during assessment timespan. Strong presence of established healthcare infrastructure facility and favorable compensation policies will steer growth of lab automation business in North America over upcoming years.
The key market participants include Qiagen N.V., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, Bio Tek Instruments, Inc., F. Hoffmann-La Roche, Hamilton Company, Aurora Biomed Inc., BMG LABTECH GMBH, Siemens Healthineers, Hudson Robotics, Eppendorf AG, Tecan Group Ltd., and PerkinElmer Inc.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed